In a group of over 3,300 Chinese adults aged 50 and older who got the shingles vaccine, about 1 in 75 had a medical visit for an adverse event within a month, and only about 1 in 300 of those events were thought to be possibly linked to the vaccine.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of multiple RCTs and cohort studies could quantify the relative risk of medically attended adverse events after RZV compared to placebo or no vaccination in adults ≥50 across diverse populations.
A systematic review and meta-analysis of all randomized controlled trials and prospective cohort studies reporting medically attended adverse events within 30 days of RZV vaccination in adults ≥50, pooling data from at least 10 studies with a combined sample size of 50,000+ participants, using standardized MedDRA coding and causality assessment criteria.
A randomized controlled trial could determine whether the incidence of medically attended adverse events is significantly higher after RZV vaccination than after placebo injection in adults ≥50.
A double-blind, placebo-controlled trial of 10,000 adults aged 50–85, randomized 1:1 to receive RZV or saline placebo, with active surveillance for medically attended events within 30 days of each dose, using standardized criteria for event classification and investigator-blinded adjudication.
A prospective cohort study with an unvaccinated control group could estimate the relative risk of medically attended adverse events following RZV vaccination in a real-world Chinese population.
A prospective cohort study of 20,000 Chinese adults aged 50–85, with 10,000 receiving RZV and 10,000 not vaccinated, followed for 12 months with monthly active surveillance for medically attended events, adjusting for age, comorbidities, and healthcare utilization patterns.
A case-control study could identify whether specific adverse events (e.g., Guillain-Barré syndrome) occur more frequently in individuals who received RZV compared to those who did not.
A matched case-control study of 500 Chinese adults aged 50+ diagnosed with a medically attended adverse event within 30 days of vaccination, each matched to two controls without the event, assessing prior RZV exposure within 60 days, with blinded exposure assessment.
A cross-sectional survey could estimate the prevalence of recent medically attended events among vaccinated and unvaccinated adults ≥50 in China at a single point in time.
A nationally representative survey of 15,000 Chinese adults aged 50+ asking about vaccination status and any medically attended adverse events within the past 30 days, using validated questionnaires and medical record verification for a subset.